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Abstract: Many wounds heal slowly and are difficult to manage. Therefore Negative 
Pressure Wound Therapy (NPWT) was developed where polymer foams are applied and a 
defined negative pressure removes wound fluid, reduces bacterial burden and increases the 
formation of granulation tissue. Although NPWT is used successfully, its mechanisms are 
not well understood. In particular, different NPWT dressings were never compared. Here a 
poly-ester urethane Degrapol® (DP)-foam was produced and compared with commercially 
available dressings (polyurethane-based and polyvinyl-alcohol-based) in terms of apparent 
pore sizes, swelling and effective interconnectivity of foam pores. DP-foams contain 
relatively small interconnected pores; PU-foams showed large pore size and 
interconnectivity; whereas PVA-foams displayed heterogeneous and poorly interconnected 
pores. PVA-foams swelled by 40 %, whereas DP- and PU-foams remained almost without 
swelling. Effective interconnectivity was investigated by submitting fluorescent beads of 3, 
20 and 45 m diameter through the foams. DP- and PU-foams removed 70-90 % of all 
beads within 4 h, independent of the bead diameter or bead pre-adsorption with serum 
albumin. For PVA-foams albumin pre-adsorbed beads circulated longer, where 20 % of 3 
m and 10 % of 20 m diameter beads circulated after 96 h. The studies indicate that 
efficient bead perfusion does not only depend on pore size and swelling capacity, but 
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effective interconnectivity might also depend on chemical composition of the foam itself. 
In addition due to the efficient sieve-effect of the foams uptake of wound components in 
vivo might occur only for short time suggesting other mechanisms being decisive for 
success of NPWT. 
 
Keywords: Degrapol®, polymer foams, pore interconnectivity, Negative Pressure Wound 
Therapy (NPWT). 
 
 
1. Introduction  
 
Each year, approximately twenty million people around the world suffer from chronic wounds 
caused by diabetes (e.g. 7.0 million diabetic ulcers), circulatory problems and many other conditions 
such as surgical site infections that generate huge demands on the health care systems [1]. Negative 
Pressure Wound Therapy (NPWT) provides an efficient method which may reduce the length of 
treatment, speed up the clearance of infections and wound closure and reduce in-hospital days [2-6]. 
Therefore NPWT is a cost effective and versatile method for many applications as compared to 
conventional and advanced wound dressings [7-9]. NPWT applies a controlled level of negative 
pressure on wounds leading to accelerated debridement and promotion of healing in many different 
types of wounds [2-4,10-12]. The effects of NPWT include the fast removal of interstitial fluid through 
the negative pressure, decrease in local edema, increased blood flow and therefore decrease tissue 
bacterial loads. However, NPWT does not replace classic methods of wound care such as debridement 
and infection treatment. Moreover, the mechanical deformation of cells in and around the wound is 
thought to result in increased matrix synthesis, which ultimately leads to an improved wound  
healing [2,13,14].  
Here poly-ester urethane Degrapol® (DP)-foams [15-17] were produced and explored for their 
potential use as NPWT dressings. Structurally, DP-polymers are block co-polyester-urethanes 
containing two different polyester blocks: a rigid one that is crystallisable and an elastic block that is 
amorphous. Due to this structure, DP has highly elastomeric properties and can be produced to have 
different shapes such as foams, fibers, fleeces with adjustable mechanical characteristics [15,18,19], 
moreover DP was shown to be cyto- and hemocompatible suggesting its use as a medical  
polymer [17,20]. 
Currently used NPWT materials consist mainly of polyurethane (PU)- or polyvinyl alcohol (PVA)-
foams (KCI Inc, [21,22]), that are placed on/into the wound site prior to application of negative 
pressure. Only very few studies report the use of alternative dressings such as an iodine-impregnated 
drapes [23,24]. PU-based foams consist of block co-polymers with hard and soft segments, where hard 
segments consist of urethane forming glassy or semi-crystalline domains [25]. Thermoplastic PUs are 
commonly used as implantable materials showing high mechanical strength, toughness, abrasion 
resistance and resistance to degradation in watery solution. PU-based materials are regarded as tissue 
tolerant and therefore often used for applications that have direct blood contact such as in  
NPWT [21,22,26,27].  
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Polyvinyl alcohol (PVA) is prepared by partial or complete hydrolysis of polyvinyl acetate to 
remove acetate groups and then polymerized. Polyvinyl alcohol has excellent film forming, 
emulsifying, and adhesive properties [28-30]. It has high tensile strength as well as flexibility. 
However these properties are dependent on humidity, such that under higher humidity conditions more 
water is absorbed. Water acts as a plasticiser reducing PVA’s tensile strength and making it softer, but 
increases its elongation and tear strength [31]. Therefore it has been clinically used to prevent post-
operative adhesions [32,33] or as cartilage replacement [31,34].  
The overall material characteristics of DP-, PU- and PVA-foams do not provide an explanation for 
the success of NPWT, therefore a comparative study to elucidate their functionality in vitro was 
performed. The aim of this study was to compare in an in vitro system DP-foams with commercially 
available PU- and PVA-foams (from KCI Inc., [14,22]) that are clinically used for NPWT. Swelling 
and pore sizes of DP-, PU and PVA foams were analyzed by scanning electron microscopy and the 
effective interconnectivity of the pores was analyzed by fluorescent bead perfusion experiments. 
Moreover, perfusion of differentially sized beads was analyzed with and without pre-adsorption of 
serum albumin to simulate more native conditions.  
 
2. Results and Discussion 
 
In this study DegraPol® (DP)-foams were produced and their potential use as dressings for negative 
pressure wound therapy (NPWT) was explored. Morphology, swelling and effective interconnectivity 
of pores that is needed when negative pressure is applied through the foams to remove wound fluid, 
bacteria and cells during the therapy was compared between DP-foams and commercially available 
foams that are clinically used for NPWT in wound healing. 
 
2.1. Morphological analysis and swelling of DP-, PU- and PVA-foams 
 
In order to compare Degrapol® (DP-) with PU- and PVA-foams, cross sections of all materials were 
analyzed by scanning electron microscopy (Figure 1a). DP-foams were porous having a homogeneous 
pore diameter of 160 ± 50 m and the pores were well interconnected (a and b). PU-foams appeared 
highly porous with a mean pore diameter of 680 ± 140 m. The pores seemed to be quite 
homogeneous in size and very much interconnected with each other, as the pores were lined only by 
slim connections resulting in an almost 3D-mesh-structure (c and d). In cross-sections of PVA-foams, 
the pores appeared variable in diameter (e and f). The mean diameter was 610 ± 420 m, where pore 
diameters ranged from 100-1100 m. The pores appeared much less interconnected with each other as 
compared to DP- and PU-foam pores and some pores even remained closed towards adjacent pores. 
After morphological characterization equilibrium swelling of the foams was compared (Figure 1b). 
The increase in diameter of DP-, PU- and PVA-foams was analyzed after swelling in either phosphate 
buffered saline (PBS) or simulated body fluid (SFB, not shown) at the indicated time points. No 
difference could be observed between the two solvents. The diameter of PVA-foams increased by ~ 41 
± 12 % showing increased softness as to be expected when PVA-foams are swollen in watery solution. 
In contrast DP- and PU-foams showed considerable less swelling (< 2 ± 3 %). Equilibrium swelling 
was reached for all types of foams after 4 h.  
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Figure 1. Morphological analysis and swelling of polymer foams. 
 
(a) DegraPol® (DP-), PU- and PVA-samples have been analyzed by scanning electron microscopy 
(Figure a, - f). Samples were swollen, chemically fixed and critical point dried followed by 
sputtering with platinum. DP-foams demonstrate homogeneous and interconnected pores with small 
pore size. PU-foams display homogeneous pores with large diameter and high interconnectivity, 
whereas PVA-foams show heterogeneous pore sizes with different amount of pore 
interconnectivity. (b) DP-, PU- and PVA-foams were swollen to equilibrium in PBS. Shown is 
percentage of swelling for the increase in diameter after the indicated time points. Data represent 
means of 4 different samples per condition ± standard deviation. The values were normalized to the 
diameter prior to swelling (= 0 % swelling). 
 
2.2. Determination of the effective interconnectivity of DP-, PU- and PVA-foams by bead perfusion 
experiments 
 
As foams when used for NPWT are exposed to a slight vacuum (usually between -80 and 125 
mmHg) this study aimed at investigating the effective interconnectivity of the pores under flow 
conditions to simulate uptake of vacuum-removed body fluids, bacteria or cell debris. Removal of 
fluorescent beads from solution was determined as a measure for the uptake of beads by the foams. As 
evident from the SEM images and from swelling experiments, differences in pore diameter and 
interconnectivity might indicate differential perfusion with fluorescence beads. Fluorescent beads of 
different diameters were used for perfusion as they correspond roughly to the size of bacteria (3 m), 
single cells (20 m) and small cell clumps (45 m) that need to pass through the foams while applied 
in NPWT. To analyze bead perfusion, a flow device was used that could harvest polymer cylinders 
with a diameter of 5 mm and 2-5 mm in length. The flow device was connected to a pump, enabling 
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continuous fluorescent bead supply and a reservoir chamber where beads were stirred by a magnetic 
stirring bar such that they did not precipitate. A schematic of the closed-loop system is shown in 
Figure 2. In initial experiments fluorescent beads of 3 and 20 m diameter were either used directly 
after rinsing extensively in PBS or after pre-adsorption with bovine serum albumin (BSA). The reason 
for this experiment was to determine whether pre-adsorption with albumin, the most frequent serum 
protein, would affect perfusion of the beads through the polymer foams (Figure 3). As the perfusion 
experiments were carried out in the presence of BSA, also the foams were pre-adsorbed thus 
simulating to a certain extent the native situation when the foams are exposed to blood and/or serum 
during their clinical application. 
 
Figure 2. Experimental setup for perfusion experiments. 
 
Schematic of the closed loop-system connecting a flow device (harbouring the sample to be 
analyzed) through silicone tubing to a pump and to a reservoir, containing the fluorescent bead 
solution. A magnetic stirrer inhibits precipitation of the beads. 
 
The bead perfusion experiments showed that BSA-adsorbed and native beads performed very 
similarly in DP- and PU-foams, as 90 and 70 %, respectively, of the 3 m diameter beads were 
entrapped after 4 h. Essentially all beads of 3 m diameter were removed from solution after 24 h. 80-
90 % of 20 m diameter beads were adsorbed after 4 h for DP- and PU-foams, respectively, and all 20 
m diameter beads were removed from solution after 24 h. In contrast, for PVA-foams, BSA-pre-
adsorption showed a difference for 3 and for 20 m diameter beads, in that 3 m diameter BSA-pre-
adsorbed beads circulated considerably longer over the entire testing period of 96 h than non-treated 
beads. 20 % of the 3 m diameter beads remained circulating even after 96 h. For 20 m diameter 
beads this effect was significant as 90 % of BSA-pre-adsorbed beads were entrapped within the foams 
only after 24 h, whereas non-treated beads were removed from the solution already after 4 h. For all 
further studies BSA-pre-adsorbed beads were used as the presence of serum albumin has to be 
considered for in vivo applications. These experiments revealed that although DP- and PU-foams 
differed considerably in their pore size the effective interconnectivity for fluorescent beads did not 
reflect the morphological appearance. Fluorescent beads were taken up by DP- and PU-foams very 
efficiently within short time and this finding was almost independent from the bead diameter as well as 
from pre-incubation of beads and scaffold with serum albumin.  
Materials 2009, 2                    
 
 
297
Figure 3. Effect of pre-adsorption with bovine serum albumin of fluorescent beads on 
perfusion time. 
 
DP-, PU- and PVA-foams were perfused with 3 and 20 m diameter fluorescent beads for 0 to 96 
h, respectively. The beads were rinsed in PBS or pre-adsorbed with 2 % bovine serum albumin 
(BSA) prior to circulation through the foams. The values represent mean values ± standard 
deviation of 3 independent samples per condition where the relative fluorescence in (%) was 
determined at indicated time points.  
 
Bead perfusion through DP-, PU- and PVA-foams was visualized microscopically as strongly 
fluorescent beads could be observed by yellow depositions on black PU- and white DP- or PVA-
foams, respectively (Figures 4a, b and c). DP-, PU- and PVA-foams were perfused for 24 h with 3 and 
20 m diameter beads. DP-foams were analyzed from the side where the bead solution entered into the 
foam (influx), a cross section through the foam and on the opposite site where the solution left 
(outflux). Although DP-foams have by far the smallest pore size, 3 m diameter beads distributed 
homogeneously throughout the entire DP-foam, as there was no visible difference between influx and 
outflux side. The cross section showed a homogeneous distribution as well. When 20 m diameter 
beads were used a clear difference was observed between influx and outflux side as the beads 
accumulated at the influx side. The cross-section indicated the flow profile of the beads within the 
lumen of the DP-foam. In PU-foams it could clearly be seen that at the incoming site beads were 
accumulated and adsorbed to the struts of the foam as well as within the foam pores (Figure 2b). This 
was observed especially for 3 m diameter beads. On the side of bead outflow, 3 m diameter beads 
were also frequently found whereas 20 m diameter beads were less visible. Surprisingly, within 
PVA-foams 3 m diameter beads penetrated very well as similar amounts of fluorescent beads were 
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visualized on both sides of the PVA-foam (Figure 4c). 20 m diameter beads penetrated less through 
the foam as fewer beads were visible at the foam surface where the beads exited.  
 
Figure 4. Perfusion of DP-, PU- and PVA-foams with BSA-pre-adsorbed and 
differentially-sized beads.  
 
DP-foams were perfused with fluorescent beads of 3 and 20 m diameter that roughly 
mimique the size of bacteria or single cells. The beads were pre-adsorbed with bovine 
serum albumin (BSA). Bead-perfused DP-foams were removed out of the flow device 
after 24 h and morphologically analyzed. The left images indicate foams that were 
exposed to the beads flowing into the foam coming from the reservoir container (inflow), 
whereas the right images display the foam surfaces of the opposite site of the foam 
(outflow). DP-foams were also shown as cross-section through the middle of the foam. 
The bottom two images show foams that were not exposed to any bead solution; left: top 
view, right: side view. The scale bar for all is 2 mm. 
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Figure 4. Cont. 
 
 
(b and c) PU- and PVA-foams were perfused with fluorescent beads of 3 and 20 and analyzed as 
described for (a). The left images indicate foams that were exposed to the beads flowing into the 
foam coming from the reservoir container (inflow), whereas the right images display the foam 
surfaces of the opposite site of the foam (outflow). The bottom two images show foams that were 
not exposed to any bead solution; left: top view, right: side view. The scale bar for all is 2 mm. 
 
 
(d) demonstrates quantification of perfusion experiments using 3, 20 and 45 m diameter beads. 
The beads were pre-adsorbed with bovine serum albumin (BSA) and the perfusion times were 
compared between DP-, PU- and PVA-foams for the given diameter of beads. The experiments 
indicate mean values ± standard deviations of three independent samples for each condition. 
 
When bead perfusion experiments were quantified and compared, it could clearly be shown that 
DP-foams behave very similar to PU-foams (Figure 4d). For 3 m diameter beads, 70 % of all beads 
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were entrapped within the DP- and PU-foams after 4 h and essentially all beads were absorbed after 24 
h; whereas in PVA-foams 60 % of the beads still permeated after 4 h and 20 % remained after 96 h. 
For 20 m diameter beads 90 % of all beads were adsorbed in DP- and PU-foams after 4 h and almost 
all beads after 24 h. In PVA-foams 20 m diameter beads circulated significantly longer and 10 % of 
the beads were still found circulating after 96 h. For 45 m diameter beads, only little difference in 
perfusion time between the three foam materials was observed, as essentially all beads were entrapped 
within DP-foams after 4 h, 90 % of the beads in PU-foams after 4 h and 80 % of the beads after 4 h in 
PVU-foams.  
The conclusion from these findings is that the pore size, swelling and interconnectivity of pores are 
not the only parameters decisive for effective bead penetration but also the chemistry of the foam, 
resulting in differential affinity between the beads and the polymer needs to be considered. Consistent 
with our findings would be that PU-foams induce very strong granulation tissue formation in vivo that 
often results in tight tissue ingrowth into the PU-foams during NPWT (personal communication D. 
M.). This is found less when PVA-foams were used. Other groups have explored PVA’s chemical 
characteristics when using PVA-films or foams in applications where tissue ingrowth is not desired 
such as to prevent postoperative adhesions [32,33].  
Our study tries to dissect NPWT-efficiency into different aspects that contribute to its successful 
use in wound healing. Here we analyzed purely materials related properties being effective foam 
interconnectivity, swelling and uptake of small particles. The length of the treatment varies depending 
the wound type and size being usually between 2 and 15 days or longer with foam changes every 2-3 
days [3,4,10]. During that time often an alternating schedule of negative pressure of -80 to -125 mmHg 
and normal pressure is applied to the wound that have been proven to be most efficient [35,36]. Two 
reasons might be thinkable why this is the most efficient way of vacuum application: one reason might 
be that NPWT dressings might clot less when alternating vacuum and non-vacuum phases are applied. 
Our study nicely showed that commercial DP-, PU- and PVA-foams uptake fluorescent beads very fast 
and that the beads accumulated within the pores of the foams. Therefore it might well be that 
alternating vacuum and non-vacuum phases might reduce the sieve-effect and therefore prolong the 
vacuum function of the NPWT dressings. Another reason might be that underlying cells are 
mechanically stimulated by alternating cycles of negative and normal pressure to form granulation 
tissue, secrete growth factors and collagens, form new blood vessels and start the healing processes 
[2,10,14]. This hypothesis has been analyzed comparatively between a finite element model of a 
wound to study cell deformation after application of strain and histological sections from tissues after 
NPWT [2]. The conclusion of their findings was that those differences in pressures and a mismatch 
between the elasticity of the wound and the NPWT-dressing result in mechanical stimulation of the 
wound that induces cell proliferation. Histological sections of wound biopsies reflected these findings 
showing increased tissue formation and vascularisation in high deformation areas [2,37]. Luckily a 
recent study demonstrates the development of a bioreactor type device that allows three-dimensional 
cell culture under subatmospheric pressure [13]. Moreover, a rodent in vivo model for NPWT was very 
recently established [14]. Therefore materials and biology-related questions that are relevant to explain 
the mechanisms of NPWT can be analyzed under more defined conditions in future studies.  
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3. Experimental Section  
 
3.1. DP-foams 
 
The polyester-urethane DP (trade name DegraPol®) was produced according to the procedure 
described by Lendlein et al. [38,39]. In brief: for the synthesis of the block copolymer, 40 wt % of 
poly(3-(R)-hydroxybutyrate)-co-(ε-caprolactone)-diol Mn = 2,660 and 60 wt % poly(ε-caprolactone)-
diol were dissolved in 1.4-dioxane and dried by heating and refluxing the solvent over molecular 
sieves (pore size 0.4 nm) situated in a Soxhlet apparatus mounted onto the reaction vessel, until the 
water content was below 20 ppm. The reaction mixture was cooled to 83 °C before the stochiometric 
amount, with respect to the two diols, of diisocyanate (TMDI) was added. After about one day of 
reaction, three portions of dibutyltin dilaurate (20 ppm) were added within one day in order to reach 
molecular weights between 60 and 110 kDa. The polymer was precipitated in dry ice cooled methanol 
and subsequently purified via dissolution in chloroform and filtration over a silicagel 60 (Fluka) 
column. A second precipitation in dry ice cooled methanol ended the process. DP-foams were 
produced by a freeze-immersion precipitation technique. A solution of DP in dioxane as solvent (5 wt 
%) was prepared and cooled to 10°C for 2 h. The cold solution was poured into a stainless steel mold 
having the shape of the desired porous body. The solution in the mold was then cooled to -25 °C in a 
laboratory freezer and kept at this temperature overnight. Afterwards the solidified structure was taken 
out of the mold and air dried at room temperature in vacuum until complete removal of the dioxane. 
Cylinders of the polymer were punched out for perfusion experiments after swelling to equilibrium. 
 
3.2. PU- and PVA-foams 
 
Sterile black polyurethane foam dressings (V.A.C.® GranuFoam®, 10 x 7.5 x 3.3 cm) and, 
polyvinyl-alcohol foam dressing (V.A.C.® WhiteFoam, 10 x 7.5 x 1 cm) were purchased from the 
V.A.C. ® T.R.A.C. ™ Therapy systems, KCI Medical Products, Wimborne, UK). Cylinders of the 
polymer were punched out for perfusion experiments after swelling to equilibrium. 
 
3.3. Swelling Experiments  
 
In order to determine the increase in diameter and length of DP-, PU- and PVA-foams when 
exposed to phosphate buffered saline (PBS) or simulated body fluid (SFB), the foams were swollen to 
equilibrium. Swelling time and amount of swelling was determined for DP- and PU-foams of 5 mm in 
diameter and 5 mm length or 5 mm in diameter and 3 mm length. PVA-foams were analyzed using 
cylinders of 5 mm in diameter and 3 mm length or 5 mm in diameter and 2 mm in length. The samples 
were immersed in PBS (Sigma, P3688-10PAK) filled up to 1 L with double distilled water (Nanopure 
diamond, Barnstead) or SFB. SBF was prepared by mixing a “Ca2+ stock solution” and a “PO43- stock 
solution” in 1: 1 ratio prior to use. The compositions of those solutions were the following: Ca2+ stock 
solution (15.99 g NaCl; 0.4474 g KCl; 0.6099 g MgCl2 x 6 H2O; 1.0955 g CaCl2 x 6 H2O); PO43- stock 
solution (0.3222 g Na2SO4 x 6 H2O; 0.7057 g NaHCO3; 0.456 5g K2HPO4 x 3 H2O; [40]). Both stock 
solutions were filled up to 1 L with double distilled water. Swelling of the foams was determined after 
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0, 1, 2, 4 and 24 h and the increase in diameter and length was determined as compared to the diameter 
and length in the dry foam (= 0 % swelling). Data represent means of 4 different samples ± standard 
deviation per condition.   
 
3.4. Flow device 
 
A custom-made flow device was used consisting of two parts A and B that could be connected 
through a screw thread leaving a sample container of 5 mm inner diameter and adjustable length (2-5 
mm) by insertion of different numbers of O-rings between parts A and B [20]. Each part was 
manufactured in poly-methyl-methacrylate (PMMA) that allowed optical inspection of the flow 
chamber. To ensure non-leakiness of the chamber, fittings for the attachment of the tubing were 
manufactured directly attached to parts A and B, respectively. TYGON R3607 silicon tubes with the 
following dimensions were used: 1.62 mm outer and 0.76 mm inner diameter. 
 
3.5. Determination of interconnectivity of the pores in DP-, PU- and PVA-foams 
 
To determine the interconnectivity of the foam pores fluorescent beads of different diameter were 
circulated through DP-, PU- and PVA-foams in a closed-loop system (Figure 2). The adsorption of the 
beads on and within the foams was assessed by decreased fluorescence of the bead solution. 3 µm 
FluoresbriteTM YG microspheres (No. 17155, Polysciences, Inc), 20 µm FluoresbriteTM YG 
microspheres (No. 19096, Polysciences, Inc) and 45 µm FluoresbriteTM YG microspheres (No. 18242, 
Polysciences, Inc) were used for the experiments. The fluorescent beads were used either native in 
PBS or after pre-adsorption with bovine serum albumin. For this purpose 100 µL of the bead solution 
was pre-adsorbed in 1 mL 2 % bovine serum albumin (BSA, Sigma, A 9418) in PBS and incubated for 
15 min, centrifuged 5 min at 10,000 rpm at room temperature. This procedure was repeated three 
times. The foams were pre-swollen in PBS at room temperature and cut into disks of 5 mm diameter 
and 5 mm length and inserted into the custom-made flow device that allowed perfusion with 
fluorescent beads. The flow rate was 8.1 mL/min using an Ismatec instruments pump (No. 7610-20). 
As the fluorescence of the circulating solution correlated with the number of fluorescent beads, two 
times 200 µL samples were extracted before and after 5, 20 min, 1 and 4 hours, and 1 and 3 days 
circulation time and transferred into white 96 well plates. The fluorescence was determined at 441 nm 
excitation and 486 nm emission wavelength both at 2.5 nm slit width in a PerkinElmer LS 55 
Luminescence Spectrometer using the provided software Flwinlab. The numbers of the fluorescent 
beads in solution submitted through the foams were 8.4 x107 for the 3 µm diameter beads, the 20 µm 
bead solution contained 284,000 beads and the 45 µm bead solution 24,950 beads, respectively. The 
fluorescence at the beginning of the experiments corresponded to the number of beads (for the 
appropriate size of beads) and has been used as a reference. At the indicated time points the actual 
fluorescence was determined and relative fluorescence = 100
nceflluoresceinitial
cefluorescenactual
 was calculated. 
The values represent mean values ± standard deviation of at least three individual experiments carried 
out in triplicate per experimental condition. All values were reduced by the value obtained for the 
solvent (PBS) only.  
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3.6. Morphological characterization of polymer foams 
 
3.6.1. Macroscope images 
 
Cylinders of DP-, PU- and PVA-foams (5 mm in diameter and 5 min in length) were swollen in 
PBS, perfused with 3 or 20 m diameter fluorescent beads for 24 h as indicated above or left in PBS 
only. The foams were fixed in 4 % paraformaldehyde dissolved in PBS for 10 min at room 
temperature. Then they were extensively rinsed with PBS and placed on a clean glass plate. The 
samples were analyzed by a Leica MZ 16A macroscope using upright light and the front lens No. 1.  
 
3.6.2. Scanning electron microscopy (SEM) 
 
Cylinders of DP-, PU- and PVA-foams (5 mm in diameter, 5 mm in length) were swollen in PBS 
and fixed in 4 % paraformaldehyde dissolved in PBS for 10 min and in 3 % glutaraldehyde in PBS for 
30 min both at room temperature. The samples were dehydrated in a graded series of ethanol. Out of 
absolute ethanol the samples were dried over the critical point of CO2 (Tk = 31 °C, Pk = 73, 8 bar) 
using a critical-point dryer (CPD 030 Critical Point Dryer, Bal-Tec AG, Balzers, Liechtenstein). The 
samples were sputter-coated with 10 nm platinum and the images were recorded with a Zeiss SUPRA 
50 VP at 1 kV and 5 kV using secondary electron signals.  
 
4. Conclusions 
 
This study demonstrates that the geometry of different NPWT dressings, even in their non-
compressed form, is not the only parameter decisive for effective bead penetration but also the 
chemistry of the foam itself resulting in differential affinity between the beads and the polymers. In 
addition due to the efficient sieve-effect of the foams uptake of vacuum-removed wound components 
in vivo might occur only for short time suggesting biological mechanisms rather than materials 
characteristics being decisive for clinical success of NPWT in wound healing. 
 
Conflict of interest 
 
None of the authors have any economical connections to the NPWT marketing companies. 
 
Acknowledgements 
 
The authors would like to thank D-MATL ETH-Zurich tool shop for excellent technical help in 
production of the flow device and ab-medica, Lainate, Italy for a fellowship for V. M. 
Materials 2009, 2                    
 
 
304
References 
  
1. http://www.prlog.org/10076809-wound-types-and-advanced-wound-products-market-worldwide 
medmarket-diligence-report-s245.html, MedMarket Diligence, LLC Dated: Jun 02, 2008, 
accessed March 20, 2009. 
2. Saxena, V.; Hwang, C.-W.; Huang, S.; Eichbaum, Q.; Ingber, D.; Orgill, D.P. Vacuum-Assisted 
Closure: Microdeformations of wounds and cell proliferation. Plast. Reconstr. Surg. 2004, 114, 
1086-1096. 
3. Jones, S.M.; Banwell, P.E.; Shakespeare, P.G. Advances in wound healing: Topical negative 
pressure therapy. Postgrad. Med. J. 2005, 81, 353-357. 
4. Kanakaris, N.K.; Thanasas, C.; Keramaris, N.; Kontakis, G.; Granick, M.S.; Giannoudis, P.V. The 
efficacy of negative pressure wound therapy in the management of lower extremity trauma: 
Review of clinical evidence. Injury Int. J. Care Injured 2007, 38S, S8-S17. 
5. Thompson, G. An overview of negative pressure wound therapy (NPWT). Br. J. Community Nurs. 
2008, 13(6), S23-4, S26, S28-S30. 
6. Ubbink, D.T.; Westerbos, S.J.; Nelson, E.A.; Vermeulen, H. A systematic review of topical 
negative pressure therapy for acute and chronic wounds. Brit. J. Surg. 2008, 95, 685–692. 
7. Gabriel, A.; Shores, J.; Heinrich, C.; Baqai, W.; Kalina, S.; Shoqioka, N., Gupta, S. Negative 
pressure wound therapy with instillation: A pilot study describing a new method for treating 
infected wounds. Int. Wound J. 2008, 5, 399-413. 
8. Flack, S.; Apelqvist, J.; Keith, M.; Truegman, P.; Williams, D. An economic evaluation of VAC 
therapy compared with wound dressings in the treatment of diabetic foot ulcers. J. Wound Care. 
2008, 17, 71-78. 
9. Ehrenreich, M.; Raszczak, Z. Tissue-engineered wound coverings. Important options for the 
clinics. Acta Dermatoven APA 2006, 15, 5-13. 
10. Labanaris, A.P.; Polykandriotis, E.; Horch, R.E. The effect of vacuum-assisted closure on lymph 
vessels in chronic wounds. J. Plast. Reconstr. Aesthet. Surg. 2008 Jun 2. [Epub ahead of print]. 
11. Körber, A.; Franckson, T.; Grabbe, S.; Dissemond, J. Vacuum assisted closure device improves 
the take of mesh grafts in chronic leg ulcer patients. Dermatology 2008, 216, 250–256. 
12. Lindstedt, S.; Malmsjö, M.; Gesslein, G.; Ingemansson, R. Topical negative pressure effects on 
coronary blood flow in a sternal wound model. International Wound Journal. 2006, 5, 503-509. 
13. Wilkes, R.P.; McNulty, A.K.; Feeley, T.D.; Schmidt, M.A.; Kieswetter, K. Bioreactor for 
application of subatmospheric pressure to three-dimensional cell culture. Tissue Eng. 2007, 13, 
3003-3010. 
14. Jacobs, S.; Simhaee, D.A.; Marsano, A.; Fomovsky, G.M.; Niedt, G.; Wu, J.K. Efficacy and 
mechanisms of vacuum-assisted closure (VAC) therapy in promoting wound healing: A rodent 
model. J. Plast. Reconstr. Aesthet. Surg . 2008 July 8. [Epub ahead of print]  
15. Danielsson, C.; Ruault, S.; Simonet, M.; Neuenschwander, P.; Frey, P. Polyesterurethane foam 
scaffold for smooth muscle cell tissue engineering. Biomaterials 2006, 8, 1410-1415. 
16. Saad, B.; Keiser, O.M.; Welti, M.; Uhlschmid, G.K.; Neuenschwander, P.; Suter, U.W. 
Multiblock copolyesters as biomaterials: In vitro biocompatibility testing. J. Mater. Sci. Mater. 
Med. 1997, 8, 497-505. 
Materials 2009, 2                    
 
 
305
17. Saad, B.; Neuenschwander, P.; Uhlschmid, G.K.; Suter, U.W. New versatile, elastomeric, 
degradable polymeric materials for medicine. Int. J. Biol. Macromol. 1999, 25, 293-301. 
18. Riboldi, S.A.; Sampaolesi, M.; Neuenschwander, P.; Cossu, G.; Mantero, S. Electrospun 
degradable polyesterurethane membranes: Potential scaffolds for skeletal muscle tissue 
engineering. Biomaterials 2005, 26, 4606-4615. 
19. Riboldi, S.A.; Sadr, N.; Pigini, L.; Neuenschwander, P.; Simonet, M.; Mognol, P.; Sampaolesi, 
M.; Cossu, G.; Mantero, S. Skeletal myogenesis on highly orientated microfibrous 
polyesterurethane scaffolds. J. Biomed. Mater. Res. A. 2008, 84, 1094-1101. 
20. Milleret, V.; Simonet, M.; Bittermann, A.G.; Neuenschwander, P.; Hall, H. Cyto- and 
hemocompatibility of a biodegradable 3DScaffold material designed for medical applications. J. 
Biomed. Mater. Res. Part B 2009, in press. 
21. Joseph, E.; Hamori, C.A.; Bergman, S.; Roaf, E.; Swann, N.; Anastas, G. Prospective randomized 
trial of vacuum- assisted closure versus standard therapy of chronic non-healing wounds. Wounds 
2000, 12, 60–67. 
22. Webb, L.X. New techniques in wound management: Vacuum-assisted wound closure. J. Am. 
Acad. Orthop. Surg. 2002, 10, 303–311. 
23. Llanos, S.; Danilla, S.; Barraza, C.; Armijo, E,; Pineros, J.L.; Quintas, M.; Searle.S.; Calderon,W. 
Effectiveness of negative pressure closure in the integration of split thickness skin grafts a 
randomized, double-masked, controlled trial. Ann. Surg. 2006, 244, 700–705. 
24. Bui, T.B.; Huerta, S.; Gordon, I.L. Negative pressure wound therapy with off-the-shelf 
components. Am. J. Surg. 2006, 192, 235–7. 
25. Dieterich, D.; Uhlig, K. Polyurethanes. In Ullmann’s Encyclopedia of Industrial Chemistry; 
Elvers, B., Hawkins, S., Schultz, G., Eds.; VCH Publishers: Cambridge, 1992; Volume A21, pp. 
665-716. 
26. Nair, P.D.; Mohanty, M.; Rathinam, K.; Javabalan, M.; Krishnamurthy, V.N. Studies of the effect 
of degree of hydrophilicity on tissue response of polyurethane interpenetrating polymer networks. 
Biomaterials 1992, 13, 537-542. 
27. Brandwood, A.; Meijs, G.F.; Gunatillake, P.A.; Noble, K.R.; Schindhelm, K.R.E. In vivo 
evaluation of polyurethanes based on novel macrodiols and MDI. J. Biomater. Sci. Polym. Ed. 
1994, 8, 41-54. 
28. DeMerlis, C.C.; Schoneker, D.R. Review of the oral toxicity of polyvinyl alcohol (PVA). Food 
Chem. Toxicol. 2003, 41, 319-326. 
29. Pal, K.; Banthia, A.K.; Majumdar, D.K. Polyvinyl alcohol-glycine composite membranes: 
Preparation, characterization, drug release and cytocompatibility studies. Biomed. Mater. 2006, 1, 
49-55. 
30. Huang, M.H., Yang, M.C. Evaluation of glucan/poly(vinyl alcohol) blend wound dressing using 
rat models. Int. J. Pharm. 2008, 346, 38–46. 
31. Stammen, J.A.; Williams, S.; Ku, D.N.; Guidberg, R.E. Mechanical properties of a novel PVA 
hydrogel in shear and unconfined compression. Biomaterials 2001, 22, 799-806. 
32. Hiraizumi, Y.; Transfeldt, E.E.; Fujimaki, E.; Nambu, M. Application of polyvinyl alcohol 
hydrogel membrane as anti-adhesive interposition after spinal surgery. Spine 1995, 20,  
2272-2277. 
Materials 2009, 2                    
 
 
306
33. Weis, C.; Odermatt, E.K.; Kressler, J.; Funke, Z.; Wehner, T.; Freytag, D. Poly(vinyl alcohol) 
membranes for adhesion prevention. J. Biomed. Mater. Res. Part. B 2004, 70B, 191–202. 
34. Oka, M.; Ushido, K.; Kumar, P.; Ikeuchi, K.; Hyon, S.H.; Nakamura, T.; Fujita, H. Development 
of artificial articular cartilage. Proc. Inst. Mech. Eng. 2000, 214, 59-68. 
35. Morykwas, M.J.; Faler, B.J.; Pearce, D.J.; Argenta, L.C. Effects of varying levels of 
subatmospheric pressure on the rate of granulation tissue formation in experimental wounds in 
swine. Ann. Plast. Surg. 2001, 47, 547-551. 
36. Morykwas, M.J.; Simpson, J.; Punger, K.; Argenta, A.; Kremers, L.; Argenta, J. Vacuum-assisted 
closure: state of basic research and physiologic foundation. Plast. Reconstr. Surg. 2006, 117  
(7 Suppl), 121S-126S. 
37. Greene, A.K.; Puder, M.; Roy, R.; Arsenault, D.; Kwei, S.; Stephanie, M.D.; Moses, M.A.; 
Dennis, P. Microdeformational wound therapy: Effects on angiogenesis and matrix 
metalloproteinases in chronic wounds of 3 debilitated patients. Ann. Plast. Surg. 2006, 56,  
418-422. 
38. Lendlein, A.; P.N.; Suter, U.W. Tissue-compatible multiblock copolymers for medical 
applications, controllable in degradation rate and mechanical properties. Macromol. Chem. Phys. 
1998, 199, 2785-2796. 
39. Lendlein, A.; Neuenschwander, P.; Suter, U.W. Hydroxy-telechelic copolyesters with well 
defined sequence structure through ring-opening polymerization. Macromol, Chem, Phys. 2000, 
201, 1067 -1076. 
40. Kokubo, T.; Takashi, N.; Fumiaki, M. Apatite formation on ceramics, metals and polymers 
induced by a CaO–SiO2 based glass in a simulated body fluid. In Bioceramics; Bonfield, W., 
Hastings, G.W., Tanner, K.E., Eds.; Butterworth-Heinemann: Oxford, UK, 1991. 
 
© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This article is an open-access article distributed under the terms and conditions of the Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 
